Anesthesia of Mucous Membrane
Conditions
Keywords
sphenopalatine ganglion block, septhorhinoplasty, general anesthesia
Brief summary
The aim of this study is to examine the effects of bilateral sphenopalatine ganglion block on surgical conditions, hemodynamics, intraoperative and postoperative analgesic use, recovery characteristics, and postoperative pain during septorhinoplasty under general anesthesia. The study was planned as double-blind, randomized, controlled. 72 patients who will undergo septorhinoplasty surgery will be collected. (g power analysis was performed.) Evaluation of the effectiveness of bilateral sphenopalatine ganglion block was planned. Patients will be divided into 2 equal groups (36 patients). After the induction of general anesthesia, one group (Group: 1) will be administered 8mg dexamethasone and 10mg bupivacaine submucosal, the other group (group:2) will be administered 4 cc saline. aspects will be evaluated.
Interventions
PROCEDUREBilateral endoscopic sphenopalatine ganglion block
After the induction of general anesthesia, one group (Group: 1) will be administered 8mg dexamethasone and 10mg bupivacaine submucosal,
PROCEDUREplacebo
Placebo group (group:2) will be administered 4 cc saline. aspects will be evaluated.
Sponsors
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
17 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
\- patients with an ASA score of I-II and between the ages of 17-45 years, who were to undergo general anesthesia with desflurane, were included in the study.
Exclusion criteria
* Patients aged \<17 and \>45 years, patients with liver and/or kidney failure, obese patients (BMI \>30), trauma patients, ASA III-IV patients, patients with bleeding disorders, those using drugs that may affect the coagulation system, patients with cardiomyopathy, cerebrovascular disease, immobility, and malnutrition were excluded from the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Numeric Rating Scale | Postoperative 0-2 hours, 2-8 hours,8-24 hours | They will be numbered from 1 to 10. 1 mildest 10 most severe pain |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| mean arterial pressure | when you come to the operating room table after anesthesia induction Intraoperative 30 minutes after extubation | mmhg |
| heart rate | when you come to the operating room table after anesthesia induction Intraoperative 30 minutes after extubation | beats\\minute |
| intraoperative remifentanil consumption | intraoperative | The intraoperative ultiva infusion dose was recorded to the patient. |
| Riker Agitation Scale | Immediately after extubation | 7 Dangerous Agitation 6 Very Agitated 5 Agitated 4 Calm and Cooperative 3 sedated 2 Very Sedated A 1 Unarousable |
| hematoma questionnaire | Postoperative 0-2 hours, 2-8 hours,8-24 hours | Hematoma was evaluated as present or absent questionnaire |
| vomiting questionnaire | Postoperative 0-2 hours, 2-8 hours,8-24 hours | was evaluated as present or absent questionnaire |
| Oral analgesic use | In the first 24 hours after surgery | Analgesic use in the first 24 hours was questioned. |
| edema questionnaire | Postoperative 0-2 hours, 2-8 hours,8-24 hours | Periorbital edema was evaluated as present or absent questionnaire |
Countries
Turkey (Türkiye)
Outcome results
None listed